Pharmaceutical Packaging Testing Equipment Market Report 2025

The pharmaceutical packaging testing equipment market size has grown steadily in recent years. It will grow from $4.12 billion in 2024 to $4.3 billion in 2025 at a compound annual growth rate (CAGR) of 4.4%. The growth in the historic period can be attributed to stringent regulatory standards, rising pharmaceutical production, focus on patient safety, globalization of pharmaceutical supply chains, increasing number of drug recalls.

The pharmaceutical packaging testing equipment market size is expected to see strong growth in the next few years. It will grow to $5.4 billion in 2029 at a compound annual growth rate (CAGR) of 5.9%. The growth in the forecast period can be attributed to continued regulatory pressure, increasing focus on sustainability, shift toward biologics and personalized medicine, innovative packaging materials, emphasis on patient safety. Major trends in the forecast period include advancements in technology, regulatory compliance, quality assurance and control, data integrity and connectivity, customization and flexibility.

The pharmaceutical packaging testing equipment market is experiencing significant growth, primarily driven by the expansion of the pharmaceutical industry. Pharmaceutical products encompass various aspects, including research, chemicals, regulations, and government involvement. The utilization of pharmaceutical packaging testing equipment contributes to the global regulatory flexibility and enhanced government collaboration, mitigating supply chain and API disruptions. Major companies, such as Eli Lilly, are investing billions to construct new manufacturing sites, exemplifying the continuous expansion of the pharmaceutical industry and its positive impact on the pharmaceutical packaging testing equipment market.

The growth of the pharmaceutical packaging testing equipment market is being driven by the rise in healthcare spending. Healthcare spending represents the total financial resources dedicated to the healthcare sector within a particular region, country, or organization. This spending utilizes pharmaceutical packaging testing equipment to guarantee the safety, integrity, and compliance of pharmaceutical products, thereby enhancing the overall quality of healthcare delivery. For example, a report released by the Office for National Statistics, a UK government department, noted that healthcare spending in the UK rose by 5.6% between 2022 and 2023, compared to a growth rate of only 0.9% in 2022. In 2023, the UK's healthcare expenditure reached approximately $317.63 billion (£292 billion). Consequently, the increase in healthcare spending is expected to propel the growth of the pharmaceutical packaging testing equipment market in the future.

Technological innovation emerges as a key trend in the pharmaceutical packaging testing equipment market. Efficient solutions for pharmaceutical and nutraceutical product distribution are facilitated by cutting-edge equipment such as hard film over wrappers, case packers, label applicators, sealers, and label applicators. The COVID-19 pandemic prompted companies to innovate, leading to the development of no-contact packaging solutions. For instance, in August 2022, Testronix Instruments launched next-generation packaging testing instruments to meet the growing demand for accuracy and reliability.

Key players in the pharmaceutical packaging testing equipment market are concentrating on creating innovative products, such as high-performance leak testers that assess the integrity of various items. A high-performance leak tester is an instrument designed to evaluate the condition of pharmaceutical packaging. For example, in November 2023, Amcor, a packaging company based in India, introduced next-generation medical laminate solutions that emphasize sustainability while ensuring high performance for medical packaging. These laminates are engineered to be recyclable within the polyethylene stream and are suitable for a range of applications, including drapes, catheters, and wound care materials.

In September 2024, Eurofins Scientific (EUFI.PA), a laboratory services company based in France, acquired Infinity Laboratories Inc. for an undisclosed sum. This acquisition enhances Eurofins' presence in the medical device and pharmaceutical testing sectors, broadening its capabilities in microbiology and sterility testing. Infinity Laboratories, a US-based company, offers high-quality testing services.

Major companies operating in the pharmaceutical packaging testing equipment market include Labthink International Inc., West Pharmaceutical Services Inc., Qualitest International Inc., AMETEK Inc., Test & Calibration, Packaging Technologies & Inspection LLC, Westpak Inc., Eurofins Scientific SE, Intertek Group plc, SGS SA, TASI Group, Edwards' Analytical Limited, NSF International, Nelson Laboratories LLC, CVC Technologies Inc., Zwick Roell Group, Lighthouse Instruments LLC, Sepha Ltd., Qualicaps Co Ltd., ACG Group, Bosch Packaging Technology, Thermo Fisher Scientific Inc., Marchesini Group, MG America Inc., Romaco Group, Uhlmann Group, Optel Group, Antares Vision Group, Mettler-Toledo International Inc.

North America was the largest region in the pharmaceutical packaging testing equipment market in 2024. The regions covered in the pharmaceutical packaging testing equipment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the pharmaceutical packaging testing equipment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Pharmaceutical packaging testing equipment pertains to solutions employed in the packaging of pharmaceutical and nutraceutical products. The equipment used for testing pharmaceutical packaging encompasses hard film overwrappers, case packers, sealers, and label applicators, and is essential in the packaging of pharmaceutical medicines.

The primary categories of pharmaceutical packaging testing equipment consist of services and equipment. Services involve intangible economic activities that necessitate personal interaction between service providers and consumers. The product category includes primary packaging equipment, secondary packaging equipment, and labeling and serialization equipment. These are utilized by various end users, including pharmaceutical companies, contract research organizations, government entities, research institutions, and testing laboratories.

The pharmaceutical packaging testing equipment market research report is one of a series of new reports that provides pharmaceutical packaging testing equipment market statistics, including pharmaceutical packaging testing equipment industry global market size, regional shares, competitors with a pharmaceutical packaging testing equipment market share, detailed pharmaceutical packaging testing equipment market segments, market trends and opportunities, and any further data you may need to thrive in the pharmaceutical packaging testing equipment industry. This pharmaceutical packaging testing equipment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The pharmaceutical packaging testing equipment market consists of sales of vials, stoppers, blisters, bottles, screw caps, and closure liners. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.